Margaret A Podlone, PA
Physician Assistant · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Margaret A Podlone’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C13250 · Deceased
Licence status: Deceased · since 1951 · Ohio State University College of Medicine.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$21,035
Medicare paid this office $21,035 for 199 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 126 | $8,911 | $63 |
| Return visit (30+ min) | 47 | $5,227 | $93 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 39 | $5,216 | $134 |
Who their Medicare patients are
199 Original Medicare patients in 2024. Average age 76 · Women 74% · Also on Medicaid 12% · Health risk score 0.85. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 66% · Diabetes 21% · Coronary heart disease 21% · Depression 18% · Chronic kidney disease 15% · Cancer 14% · Atrial fibrillation 14% · Heart failure 9% · COPD 9%.
The office billed $68,787, Medicare allowed $27,653 and paid $21,035; for 253 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 199 | 253 | 76 | 0.85 | $68,787 | $21,035 |
| 2023 | 151 | 175 | 76 | 0.76 | $42,404 | $12,955 |
| 2022 | 93 | 110 | 73 | 0.81 | $23,949 | $7,330 |
| 2021 | 57 | 79 | 72 | 0.73 | $16,929 | $6,203 |
| 2020 | 73 | 84 | 71 | 0.63 | $13,750 | $2,946 |
| 2019 | 149 | 197 | 72 | 0.86 | $40,886 | $10,373 |
| 2018 | 149 | 200 | 70 | 0.88 | $42,408 | $10,405 |
| 2017 | 145 | 314 | 70 | 0.88 | $41,290 | $9,996 |
| 2016 | 132 | 177 | 70 | 0.84 | $35,965 | $8,413 |
| 2015 | 107 | 362 | 70 | 0.80 | $31,038 | $7,678 |
| 2014 | 75 | 100 | 68 | 1.06 | $18,468 | $4,382 |
| 2013 | 83 | 116 | 69 | 0.63 | $20,440 | $4,563 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Short return visit (20+ min) | 116 | $7,781 | $65 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,305 | $136 |
| Return visit (30+ min) | 21 | $1,922 | $87 |
2022: 1 service
| Short return visit (20+ min) | 75 | $5,191 | $65 |
2021: 2 services
| Short return visit (20+ min) | 40 | $2,930 | $65 |
| Return visit (30+ min) | 11 | $1,191 | $108 |
2020: 2 services
| Short return visit (20+ min) | 36 | $1,265 | $33 |
| Telephone medical discussion with physician, 5-10 minutes | 22 | $860 | $39 |
2019: 2 services
| Short return visit (20+ min) | 122 | $6,634 | $48 |
| Return visit (30+ min) | 18 | $1,577 | $88 |
2018: 2 services
| Short return visit (20+ min) | 114 | $5,463 | $44 |
| Return visit (30+ min) | 28 | $2,342 | $73 |
2017: 2 services
| Short return visit (20+ min) | 120 | $6,189 | $44 |
| Return visit (30+ min) | 21 | $1,378 | $66 |
2016: 2 services
| Short return visit (20+ min) | 110 | $5,696 | $45 |
| Return visit (30+ min) | 16 | $941 | $59 |
2015: 2 services
| Short return visit (20+ min) | 93 | $4,440 | $40 |
| Return visit (30+ min) | 11 | $842 | $77 |
2014: 1 service
| Short return visit (20+ min) | 65 | $3,590 | $45 |
2013: 1 service
| Short return visit (20+ min) | 72 | $3,572 | $42 |
Drugs they prescribed that Part D paid
$15,253
Pharmacies billed $15,253 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
263 generic and fewer than 11 brand-name prescriptions · $15,253 in drug cost · 44 antibiotic prescriptions to 39 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fluticasone Propionate | 11 | $284 | $26 |
| Gabapentin | 11 | $188 | $17 |
| Furosemide | 11 | $65 | $6 |
| Amlodipine Besylate | 12 | $43 | $4 |
| Azithromycin | 12 | $25 | $2 |
Year by year
| 2024 | 294 | 141 | None | None | $15,253 |
| 2023 | 216 | 106 | None | 6% | $17,760 |
| 2022 | 202 | 91 | None | 7% | $9,869 |
| 2021 | 224 | 84 | None | None | $8,064 |
| 2020 | 274 | 92 | None | 5% | $7,974 |
| 2019 | 277 | 124 | 6% (17) | 6% | $6,692 |
| 2018 | 301 | 132 | 4% (11) | 16% | $12,870 |
| 2017 | 214 | 106 | None | 13% | $7,203 |
| 2016 | 244 | 112 | 9% (21) | 15% | $15,226 |
| 2015 | 312 | 112 | 9% (27) | 13% | $14,614 |
| 2014 | 347 | 95 | 3% (11) | 21% | $28,271 |
| 2013 | 353 | 109 | 4% (14) | None | $19,693 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Fluticasone Propionate | 12 | $300 | $25 |
| Amlodipine Besylate | 13 | $214 | $16 |
| Paxlovid (Eua) | 14 | $143 | $10 |
2022: 2 drugs
| Levothyroxine | 14 | $446 | $32 |
| Amlodipine Besylate | 11 | $126 | $11 |
2021: 3 drugs
| Levothyroxine | 26 | $634 | $24 |
| Trazodone | 13 | $241 | $19 |
| Amlodipine Besylate | 16 | $131 | $8 |
2020: 5 drugs
| Omeprazole | 18 | $281 | $16 |
| Trazodone | 18 | $192 | $11 |
| Lisinopril | 11 | $137 | $12 |
| Amlodipine Besylate | 19 | $115 | $6 |
| Simvastatin | 12 | $112 | $9 |
2019: 3 drugs
| Omeprazole | 18 | $335 | $19 |
| Trazodone | 17 | $187 | $11 |
| Azithromycin | 14 | $86 | $6 |
2018: 4 drugs
| Fluticasone Propionate | 15 | $258 | $17 |
| Omeprazole | 11 | $111 | $10 |
| Azithromycin | 14 | $82 | $6 |
| Simvastatin | 12 | $43 | $4 |
2017: 4 drugs
| Proair Hfa | 12 | $1,123 | $94 |
| Fluticasone Propionate | 14 | $238 | $17 |
| Azithromycin | 13 | $72 | $6 |
| Simvastatin | 11 | $52 | $5 |
2016: 4 drugs
| Hydrocodone-Acetaminophen | 16 | $399 | $25 |
| Fluticasone Propionate | 17 | $367 | $22 |
| Azithromycin | 15 | $127 | $8 |
| Simvastatin | 13 | $110 | $8 |
2015: 5 drugs
| Hydrocodone-Acetaminophen | 19 | $757 | $40 |
| Fluticasone Propionate | 41 | $494 | $12 |
| Digox | 12 | $392 | $33 |
| Azithromycin | 20 | $144 | $7 |
| Sertraline | 12 | $102 | $9 |
2014: 4 drugs
| Fluticasone Propionate | 17 | $248 | $15 |
| Simvastatin | 11 | $136 | $12 |
| Azithromycin | 14 | $111 | $8 |
| Sertraline | 12 | $80 | $7 |
2013: 8 drugs
| Lantus | 11 | $1,649 | $150 |
| Amlodipine Besylate | 19 | $282 | $15 |
| Simvastatin | 20 | $280 | $14 |
| Fluticasone Propionate | 11 | $258 | $23 |
| Zolpidem | 19 | $183 | $10 |
| Azithromycin | 13 | $133 | $10 |
| Lisinopril | 11 | $94 | $9 |
| Atenolol | 12 | $78 | $6 |
Money from drug and device companies
$231 in 2025
| 2025 | 2 | 2 | None | $231 |
| 2024 | 4 | 4 | None | $440 |
| 2023 | 3 | 4 | None | $437 |
| 2022 | 5 | 7 | None | $735 |
| 2021 | 3 | 3 | None | $272 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Madrigal Pharmaceuticals | Rezdiffra | $125 | 1 payment
|
| Gilead Sciences | Epclusa | $106 | 1 payment
|
See all 2 published payments
| Madrigal Pharmaceuticals | Meals · 2025-04-17 | Rezdiffra | $125 |
| Gilead Sciences | Meals · 2025-02-19 | Epclusa | $106 |
See earlier years (2024, 2023, 2022, 2021)
2024: $440
| Neurocrine Biosciences | Ingrezza | $136 | 1 payment
|
| Gilead Sciences | Epclusa | $122 | 1 payment
|
| Sage Therapeutics | None | $96 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $87 | 1 payment
|
2023: $437
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $231 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $106 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $99 | 1 payment
|
2022: $735
| Amgen | Evenity | $308 | 3 payments
|
| Otsuka Pharmaceutical Development & Commercialization | None | $134 | 1 payment
|
| Abbvie | Vraylar | $125 | 1 payment
|
| Eisai | None | $108 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $60 | 1 payment
|
2021: $272
| Biohaven Pharmaceuticals | Nurtec Odt | $109 | 1 payment
|
| Amgen | Repatha | $102 | 1 payment
|
| Coloplast | Restorelle | $62 | 1 payment
|
Professional record
- NPI
- 1447348123
- Licence
- CA 13250California C13250: Deceased
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 701 E El Camino Real, Mountain View, CA, 94040
- NPI first listed
- 2006-10-10
- NPI last updated
- 2009-03-05
This is when the NPI record was last certified, not a medical board exam.